Recent Updates
Recently added Catalysts
TVTX Positive Sentiment

Travere Therapeutics to Present at the Stifel 2026 Virtual Immunology and Inflammation Forum

Thursday, September 17, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Travere Therapeutics, Inc. announced that its management will present at the Stifel 2026 Virtual Immunology and Inflammation Forum on September 24, 2026. The presentation is scheduled for 10:30 a.m. ET and will be available via a live webcast on the company's investor page. A replay of the event will be accessible for 30 days post-presentation.

Market Sentiment Analysis

POSITIVE FACTORS

  • Travere Therapeutics is actively participating in a significant industry forum.
  • The presentation will be accessible via a live webcast, enhancing visibility.
  • Replay availability for 30 days allows broader audience engagement.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+68%
120-day peak, hindsight
Typical move
8.6%
average across 10 past catalysts
Lead asset
Sparsentan
Phase 3 · Immunoglobulin A Nephropathy

Full Press Release Details

SAN DIEGO--(BUSINESS WIRE)--Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that company management will present at the Stifel 2026 Virtual Immunology and Inflammation Forum on Thursday, September 24, 2026, at 10:30 a.m. ET.Live webcast of the presentation will be accessible on the Investor page of Travere’s website at ir.travere.com/events-and-presentations. Replay will be available for up to 30 days following the event.About Travere TherapeuticsAt Travere Therapeutics, we are in rare

Frequently Asked Questions

When will Travere Therapeutics present at the forum?

Travere Therapeutics will present on September 24, 2026, at 10:30 a.m. ET.

How can I access the presentation?

The presentation will be available via a live webcast on Travere's investor page.

Will there be a replay of the presentation?

Yes, a replay will be available for up to 30 days after the event.

What is the focus of the Stifel 2026 Forum?

The forum focuses on immunology and inflammation topics.

ShareAdd on Google
Tags: TVTX Viatris Investor Conferences Healthcare Travere Therapeutics Stifel Forum Immunology Inflammation
Last updated: Sep 17, 2026

Biotech snapshot

Cash runway
$489M liquidity · $0M/mo burn
Low dilution risk
Lead asset
SparsentanPhase 3
Immunoglobulin A Nephropathy →

Catalyst track record

+68%
best trade around TVTX's most recent catalyst

Peak hindsight return over a 120-day window, across 10 tracked FDA/PDUFA catalysts for TVTX.

See every catalyst's timing & PoA →